Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Código QR

Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/37bba60754944344b28ec4d028ad3b41
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
por: Schieber M, et al.
Publicado: (2019)

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia
por: Carmen D. Herling, et al.
Publicado: (2018)

Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Huicheng Liu, et al.
Publicado: (2021)

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
por: Fatih M. Uckun, et al.
Publicado: (2021)

ANTI-APOPTOTIC EFFECT OF CD95 RECEPTOR IN NA VE CD8+ T-LYMPHOCYTES IN CHILDREN WITH ACUTE INFECTIOUS MONONUCLEOSIS
por: E. N. Filatova, et al.
Publicado: (2016)

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
por: Gabriele Brachtl, et al.
Publicado: (2011)

Chronic lymphocytic leukemia/small lymphocytic lymphoma
por: E. A. Nikitin, et al.
Publicado: (2020)

Lymphoma & Chronic Lymphocytic Leukemias

Chronic lymphocytic leukemia in general practice
por: Đurović Ljiljana P.
Publicado: (2021)

An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017)

An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)

Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.
por: Silvia Catellani, et al.
Publicado: (2011)

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
por: Sylvain Garciaz, et al.
Publicado: (2021)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
por: T. V. Tyrinova, et al.
Publicado: (2012)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
por: Burgstaller S, et al.
Publicado: (2014)

Extensive Proliferation of Cd4+ Lymphocyte by Both Phytohaemagglutinin A and Anti-Cd2/Cd3/ Cd28 Macsibeads
por: Mirzakhani M., et al.
Publicado: (2018)

Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow
por: Huynh Cao, et al.
Publicado: (2021)

Evaluation of CD3 and CD4 Positive Lymphocytes in Trichomonas Vaginalis Infection
por: AR Abdollahi, et al.
Publicado: (2011)

Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter K, et al.
Publicado: (2015)

Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia.
por: Maciej Grzywnowicz, et al.
Publicado: (2012)

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
por: Lucia Gozzo, et al.
Publicado: (2021)

VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
por: Melda Cömert, et al.
Publicado: (2021)

Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.
por: Amit K Mittal, et al.
Publicado: (2013)

THE ROLE OF SUBPOPULATIONS OF CD8+ T LYMPHOCYTES IN THE DEVELOPMENT OF PREGNANCY
por: O. I. Stepanova, et al.
Publicado: (2018)

Continuous Modeling of T CD4 Lymphocyte Activation and Function
por: David Martínez-Méndez, et al.
Publicado: (2021)

Professor Raymond Dart
por: J. D. Verster
Publicado: (1961)

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
por: Diego Farinello, et al.
Publicado: (2018)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Sayaka Kiso, et al.
Publicado: (2021)

Expression of CD25+ and CD95+ Surface Markers on Peripheral Blood Lymphocytes in Patients with Vibration Disease
por: S. I. Kurchevenko, et al.
Publicado: (2020)

Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
por: Meike Farber, et al.
Publicado: (2021)

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia
por: Janek S. Walker, et al.
Publicado: (2021)

CD20<sup>+</sup>B LYMPHOCYTES, A HIGHLY INFORMATIVE BIOMARKER FOR EARLY DIAGNOSIS OF CHRONIC ENDOMETRITIS
por: V. N. Ellinidi, et al.
Publicado: (2019)

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Ana Colado, et al.
Publicado: (2021)

FEATURES OF IMMUNOCOMPETENT CELLS IN THE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT PRIMARY DIAGNOSIS
por: N. V. Isaeva, et al.
Publicado: (2016)

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
por: M. N Khorobrykh, et al.
Publicado: (2014)

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Francesco Autore, et al.
Publicado: (2021)